This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the purchase of naloxone hydrochloride, a critical drug used to reverse opioid overdoses. The Maclean Group has an extensive history of providing a wide range of medical equipment, water treatment systems, and other products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price purchase order contract worth $2,010.06 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride. The contract has a performance period ending on May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that provides a range of products and services to federal...
This federal contract award, valued at $2,010.06, was issued by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the procurement of naloxone hydrochloride. The contract has an ultimate completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that specializes in supplying a wide range of products and services to various...
This federal contract award, valued at $2,010.06, was issued by the Medical Supply Chain division of the U.S. Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is a firm-fixed-price purchase order for the delivery of 8510598494 ! NALOXONE HYDROCHLOR, a medical product, with a completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical...
This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510696704 - Naloxone Hydrochloride, a critical drug used to treat opioid overdose. The award has a completion date of June 18, 2024 and is structured as a firm fixed price purchase order. The Maclean Group LLC is an ISO...
The U.S. Defense Logistics Agency (DLA) awarded a $2,010.06 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of 8510594132 - Naloxone Hydrochloride. The contract does not have a set-aside designation and has an ultimate completion date of May 10, 2024. The Maclean Group is a medical and pharmaceutical wholesale distributor that holds several significant federal...
The U.S. Defense agency, the Medical Supply Chain, awarded a $1,005.03 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510975929 – NALOXONE HYDROCHLORIDE and has an ultimate completion date of November 7, 2024. The Maclean Group LLC is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has secured multiple...
This contract award to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, is for the supply of naloxone hydrochloride to the Department of Defense's Medical Supply Chain. The fixed-price purchase order has a ceiling value of $1,005.03 and a completion date of September 25, 2024. The Maclean Group has previously supplied a variety of medical equipment, water treatment systems, and support services to federal agencies...
The U.S. Department of Defense's Medical Supply Chain (also known as VPDLATSMED-A) has awarded a $1,005.03 firm fixed-price purchase order to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the delivery of 8510639233 - Naloxone Hydrochloride. This order has an ultimate completion date of May 31, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded numerous prime...
This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded numerous prime federal...